Djillali Annane, MD, Hôpital Raymond-Poincare – Univ Paris Saclay-UVSQ, Garches, France
Monday, November 7, 2022
8:00 to 8:10 am CT US
"Anti-c5a Vilobelimab Reduces All-cause Mortality in Critically Ill Covid-19 Patients and in Those with Comorbid Hypertension: A Phase 3 Randomized Double-blind, Placebo-controlled Study"
<< back to list